Fineline Cube

Follow:
14435 Articles
AstraZeneca's FLAURA2 Study Confirms Osimertinib Combo's Survival Benefit in NSCLC
CompanyDrug

AstraZeneca’s FLAURA2 Study Confirms Osimertinib Combo’s Survival Benefit in NSCLC

Joincare's LZM012 Meets Phase III Endpoint for Psoriasis Treatment
CompanyDrug

Livzon Pharma’s LZM012 Meets Phase III Endpoint for Psoriasis Treatment

Simcere Zaiming Receives FDA Clearance for Phase I Trial of FGFR2b-Targeting ADC SIM0686
CompanyDrug

Simcere Zaiming Receives FDA Clearance for Phase I Trial of FGFR2b-Targeting ADC SIM0686

Abbott Reports Q2 2025 Sales of USD 11.14 Billion, Led by Medical Devices Growth
Company

Abbott Reports Q2 2025 Sales of USD 11.14 Billion, Led by Medical Devices Growth

DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation
CompanyDrug

DualityBio’s Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

Shanghai Pharma and Cutia Therapeutic Collaborate on Codon Biopharma's Innovative Drug Distribution
CompanyDeals

Shanghai Pharma and Cutia Therapeutic Collaborate on Codon Biopharma’s Innovative Drug Distribution

Bio-Thera's BAT4406F Gets NMPA Nod for MCD and FSGS Clinical Trials
CompanyDrug

Bio-Thera’s BAT4406F Gets NMPA Nod for MCD and FSGS Clinical Trials

Huadong Medicine Receives NMPA Approval for HDM2012 Clinical Trials in Advanced Solid Tumors
CompanyDrug

Huadong Medicine Receives NMPA Approval for HDM2012 Clinical Trials in Advanced Solid Tumors

Optoseeker Biotech and BioMap Collaborate to Accelerate Antibody Therapeutics Development
CompanyDeals

Optoseeker Biotech and BioMap Collaborate to Accelerate Antibody Therapeutics Development

Wondfo Biotech's MSI Detection Kit Granted NMPA Marketing Clearance
CompanyMedical Device

Wondfo Biotech’s MSI Detection Kit Granted NMPA Marketing Clearance

Zhongke Yian Receives NMPA Approval for Innovative Sirolimus-Eluting Coronary Stent
CompanyMedical Device

Zhongke Yian Receives NMPA Approval for Innovative Sirolimus-Eluting Coronary Stent

NMPA Approves World's First Plant-Based Human Albumin for Liver Cirrhosis Treatment
CompanyDrug

NMPA Approves World’s First Plant-Based Human Albumin for Liver Cirrhosis Treatment